RAISE_2A: RAISE, figure 2A

RAISE_2AR Documentation

RAISE, figure 2A

Description

Kaplan-Meier digitized data from RAISE, figure 2A (PMID 25877855). A reported sample size of 1,072 for a primary endpoint of OS in colorectal cancer.

Usage

RAISE_2A

Format

A data frame of 1,072 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (placebo_folfiri, ramucirumab_folfiri)

Source

Tabernero J, Yoshino T, Cohn AL, et al. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Lancet Oncol 2015; 16: 499–508.

Examples

summary(RAISE_2A)

kmplot(RAISE_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.